Friedrich Grimminger

45.0k total citations · 7 hit papers
556 papers, 31.3k citations indexed

About

Friedrich Grimminger is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Friedrich Grimminger has authored 556 papers receiving a total of 31.3k indexed citations (citations by other indexed papers that have themselves been cited), including 371 papers in Pulmonary and Respiratory Medicine, 131 papers in Physiology and 116 papers in Molecular Biology. Recurrent topics in Friedrich Grimminger's work include Pulmonary Hypertension Research and Treatments (240 papers), Nitric Oxide and Endothelin Effects (82 papers) and Neonatal Respiratory Health Research (59 papers). Friedrich Grimminger is often cited by papers focused on Pulmonary Hypertension Research and Treatments (240 papers), Nitric Oxide and Endothelin Effects (82 papers) and Neonatal Respiratory Health Research (59 papers). Friedrich Grimminger collaborates with scholars based in Germany, United States and United Kingdom. Friedrich Grimminger's co-authors include Werner Seeger, Hossein Ardeschir Ghofrani, Ralph T. Schermuly, Norbert Weißmann, D. Walmrath, Horst Olschewski, Frank Rose, Andreas Günther, Soni Savai Pullamsetti and Konstantin Mayer and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Friedrich Grimminger

543 papers receiving 30.5k citations

Hit Papers

Riociguat for the Treatme... 1998 2026 2007 2016 2013 2013 2011 2009 2002 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Riociguat for the Treatment of Pulmonary Arterial Hypertension
    2013 944 citations Hossein Ardeschir Ghofrani, Nazzareno Galiè et al. profile →
  2. Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
    2013 911 citations Hossein Ardeschir Ghofrani, Friedrich Grimminger et al. profile →
  3. Mechanisms of disease: pulmonary arterial hypertension
    2011 614 citations Ralph T. Schermuly, Hossein Ardeschir Ghofrani et al. profile →
  4. Inflammation, Growth Factors, and Pulmonary Vascular Remodeling
    2009 557 citations Paul M. Hassoun, Friedrich Grimminger et al. profile →
  5. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
    2002 537 citations Hossein Ardeschir Ghofrani, Frank Rose et al. profile →
  6. Real-time quantitative RT–PCR after laser-assisted cell picking
    1998 521 citations Ludger Fink, Werner Seeger et al. profile →
  7. Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension
    2013 411 citations Marius M. Hoeper, Robyn J. Barst et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Friedrich Grimminger Germany 90 18.5k 8.3k 7.2k 5.7k 3.4k 556 31.3k
Rubin M. Tuder United States 98 20.6k 1.1× 5.4k 0.7× 9.7k 1.4× 5.0k 0.9× 3.6k 1.1× 330 33.1k
Norbert F. Voelkel United States 84 16.8k 0.9× 8.1k 1.0× 6.1k 0.9× 3.0k 0.5× 2.0k 0.6× 274 24.8k
Stephen L. Archer United States 89 17.7k 1.0× 11.6k 1.4× 11.1k 1.6× 6.5k 1.1× 939 0.3× 306 33.5k
Hossein Ardeschir Ghofrani Germany 86 27.9k 1.5× 17.9k 2.2× 5.2k 0.7× 4.0k 0.7× 1.1k 0.3× 635 34.8k
Lilach O. Lerman United States 84 7.0k 0.4× 7.9k 1.0× 7.3k 1.0× 4.0k 0.7× 2.4k 0.7× 674 29.6k
Hiroaki Shimokawa Japan 103 5.3k 0.3× 18.0k 2.2× 10.6k 1.5× 10.9k 1.9× 2.6k 0.8× 841 40.2k
Toshiro Fujita Japan 97 3.9k 0.2× 5.2k 0.6× 13.8k 1.9× 4.4k 0.8× 2.3k 0.7× 706 38.5k
Joe G. N. Garcia United States 92 7.3k 0.4× 2.2k 0.3× 15.3k 2.1× 5.1k 0.9× 5.1k 1.5× 577 30.8k
John P. Cooke United States 101 3.5k 0.2× 10.9k 1.3× 11.2k 1.6× 11.8k 2.1× 2.9k 0.9× 510 35.6k
Horst Olschewski Austria 69 17.2k 0.9× 10.3k 1.2× 2.5k 0.3× 2.4k 0.4× 466 0.1× 334 21.3k

Countries citing papers authored by Friedrich Grimminger

Since Specialization
Citations

This map shows the geographic impact of Friedrich Grimminger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Friedrich Grimminger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Friedrich Grimminger more than expected).

Fields of papers citing papers by Friedrich Grimminger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Friedrich Grimminger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Friedrich Grimminger. The network helps show where Friedrich Grimminger may publish in the future.

Co-authorship network of co-authors of Friedrich Grimminger

This figure shows the co-authorship network connecting the top 25 collaborators of Friedrich Grimminger. A scholar is included among the top collaborators of Friedrich Grimminger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Friedrich Grimminger. Friedrich Grimminger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Xiang, Andreas Weigert, Simone Reu, et al.. (2020). Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non–Small Cell Lung Carcinoma. Cancer Research. 80(20). 4414–4425. 154 indexed citations
2.
Hoeper, Marius M., Robyn J. Barst, Robert C. Bourge, et al.. (2013). Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension. Circulation. 127(10). 1128–1138. 411 indexed citations breakdown →
3.
Dahal, Bhola K., Djuro Kosanovic, Josef Messinger, et al.. (2011). Role of mast cells and chymase in pulmonary vascular remodeling. European Respiratory Journal. 38(Suppl 55). p1524–p1524. 1 indexed citations
4.
Savai, Rajkumar, Ralph T. Schermuly, Soni Savai Pullamsetti, et al.. (2007). A Combination Hybrid-Based Vaccination/Adoptive Cellular Therapy to Prevent Tumor Growth by Involvement of T Cells. Cancer Research. 67(11). 5443–5453. 21 indexed citations
5.
Seeger, Werner & Friedrich Grimminger. (2005). Announcement Review Focus on Hypoxia and the Pulmonary Circulation. Cardiovascular Research. 68(1). vi–vi. 1 indexed citations
6.
Seeger, Werner & Friedrich Grimminger. (2005). Announcement Review Focus on Hypoxia and the Pulmonary Circulation. Cardiovascular Research. 69(1). vi–vi. 1 indexed citations
7.
Rose, Frank, Friedrich Grimminger, Norbert Weißmann, et al.. (2002). Hypoxic pulmonary artery fibroblasts trigger proliferation of vascular smooth muscle cells‐role of hypoxia‐inducible transcription factors. The FASEB Journal. 16(12). 1660–1661. 90 indexed citations
8.
Schermuly, Ralph T., Christian Schudt, Norbert Weißmann, et al.. (2001). Coaerosolization of Phosphodiesterase Inhibitors Markedly Enhances the Pulmonary Vasodilatory Response to Inhaled Iloprost in Experimental Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 164(9). 1694–1700. 47 indexed citations
9.
Schmidt, Reinhold E., Ute‐Christiane Meier, D. Walmrath, et al.. (2001). Alteration of Fatty Acid Profiles in Different Pulmonary Surfactant Phospholipids in Acute Respiratory Distress Syndrome and Severe Pneumonia. American Journal of Respiratory and Critical Care Medicine. 163(1). 95–100. 115 indexed citations
10.
Schütte, Hartwig, Konstantin Mayer, Heiko Bürger, et al.. (2001). Endogenous Nitric Oxide Synthesis and Vascular Leakage in Ischemic-Reperfused Rabbit Lungs. American Journal of Respiratory and Critical Care Medicine. 164(3). 412–418. 13 indexed citations
11.
Schermuly, Ralph T., Andreas Günther, Norbert Weißmann, et al.. (2000). Differential Impact of Ultrasonically Nebulized Versus Tracheal-instilled Surfactant on Ventilation-Perfusion (V A /Q) Mismatch in a Model of Acute Lung Injury. American Journal of Respiratory and Critical Care Medicine. 161(1). 152–159. 27 indexed citations
12.
Kiss, Ladislau, Hartwig Schütte, Konstantin Mayer, et al.. (2000). Synthesis of Arachidonic Acid–Derived Lipoxygenase and Cytochrome P450 Products in the Intact Human Lung Vasculature. American Journal of Respiratory and Critical Care Medicine. 161(6). 1917–1923. 41 indexed citations
13.
Schulz, Richard, Siamak Mahmoudi, Katja Hattar, et al.. (2000). Enhanced Release of Superoxide from Polymorphonuclear Neutrophils in Obstructive Sleep Apnea. American Journal of Respiratory and Critical Care Medicine. 162(2). 566–570. 485 indexed citations
14.
Schütte, Hartwig, et al.. (1999). Ventilation–Perfusion Mismatch after Lung Ischemia–Reperfusion: Protective Effect of Nitric Oxide. American Journal of Respiratory and Critical Care Medicine. 160(4). 1179–1187. 32 indexed citations
15.
Schermuly, Ralph T., Hossein Ardeschir Ghofrani, Beate Enke, et al.. (1999). Low-dose Systemic Phosphodiesterase Inhibitors Amplify the Pulmonary Vasodilatory Response to Inhaled Prostacyclin in Experimental Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 160(5). 1500–1506. 53 indexed citations
16.
Olschewski, Horst, Hossein Ardeschir Ghofrani, D. Walmrath, et al.. (1999). Inhaled Prostacyclin and Iloprost in Severe Pulmonary Hypertension Secondary to Lung Fibrosis. American Journal of Respiratory and Critical Care Medicine. 160(2). 600–607. 300 indexed citations
17.
Temmesfeld‐Wollbrück, Bettina, et al.. (1998). Abnormalities of Gastric Mucosal Oxygenation in Septic Shock: Partial Responsiveness to Dopexamine. American Journal of Respiratory and Critical Care Medicine. 157(5). 1586–1592. 92 indexed citations
18.
Schütte, Hartwig, Konstantin Mayer, Tobias Gessler, et al.. (1998). Nitric Oxide Biosynthesis in an Exotoxin-induced Septic Lung Model: Role of cNOS and Impact on Pulmonary Hemodynamics. American Journal of Respiratory and Critical Care Medicine. 157(2). 498–504. 15 indexed citations
19.
Schütte, Hartwig, et al.. (1998). Vascular Distension and Continued Ventilation Are Protective in Lung Ischemia/Reperfusion. American Journal of Respiratory and Critical Care Medicine. 157(1). 171–177. 28 indexed citations
20.
Schermuly, Ralph T., Thomas Schmehl, Andreas Günther, et al.. (1997). Ultrasonic Nebulization for Efficient Delivery of Surfactant in a Model of Acute Lung Injury. American Journal of Respiratory and Critical Care Medicine. 156(2). 445–453. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rubin M. Tuder Breakdown of academic impact, for papers by Norbert F. Voelkel Breakdown of academic impact, for papers by Stephen L. Archer Breakdown of academic impact, for papers by Hossein Ardeschir Ghofrani Breakdown of academic impact, for papers by Lilach O. Lerman Breakdown of academic impact, for papers by Hiroaki Shimokawa Breakdown of academic impact, for papers by Toshiro Fujita Breakdown of academic impact, for papers by Joe G. N. Garcia Breakdown of academic impact, for papers by John P. Cooke Breakdown of academic impact, for papers by Horst Olschewski
Rankless by CCL
2026